Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Aerium Therapeutics Logo
Aerium Therapeutics (closed)
Aerium Therapeutics is discovering and developing novel monoclonal antibodies (mAbs) and antiviral treatments against SARS-CoV-2 variants.
Closed Founded
obfuscation
PrivateSeries A Boston, Massachusetts, United States1-10 www.aeriumtx.com/
Biopharma
Health Care
Medical
Pharmaceutical
Therapeutics

Aerium Therapeutics is permanently closed. If you feel this is an error, let us know.

Overview

Aerium Therapeutics
Heat Score
32

Growth Score
pts
in past quarter
Heat Score 32
-38 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Aerium Therapeutics

Aerium Therapeutics is discovering and developing novel monoclonal antibodies (mAbs) and antiviral treatments against SARS-CoV-2 variants.
Closed Founded
obfuscation
PrivateSeries A Boston, Massachusetts, United States1-10 www.aeriumtx.com/
Biopharma
Health Care
Medical
Pharmaceutical
Therapeutics

Funding Rounds

Series A
OBF
in
obfuscation

Key People

  • Photo of Kathryn Stecco
    Kathryn Stecco: Senior Director, Medical Monitor
    Past Role: Panther Orthopedics, CEO and Co-Founder

Details

Legal Name Aerium Therapeutics
Operating Status Closed
Company Type For Profit
About the Company
Aerium Therapeutics is discovering and developing novel monoclonal antibodies (mAbs) and antiviral treatments against SARS-CoV-2 variants.
Contact Email info@aeriumtx.com
Predictions & Insights

Products & Services

AER800
A combination of two long-acting monoclonal antibodies, AER003 and AER004, designed to protect immunocompromised individuals from severe COVID-19 by targeting the ACE2 binding site of the SARS-CoV-2 receptor binding domain.
AER003
A monoclonal antibody that binds to the receptor binding domain of SARS-CoV-2, providing a high barrier to virus escape.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Aerium Therapeutics Logo
Series A - Aerium Therapeutics
2
obfuscation
Omega FundsSeries A
obfuscation
Series A - Aerium Therapeutics Logo
Series A - Aerium Therapeutics
2
obfuscation
Omega FundsSeries A
obfuscation
Series A - Aerium Therapeutics Logo
Series A - Aerium Therapeutics
2
obfuscation
Omega FundsSeries A
obfuscation
Series A - Aerium Therapeutics Logo
Series A - Aerium Therapeutics
2
obfuscation
Omega FundsSeries A
obfuscation
Series A - Aerium Therapeutics Logo
Series A - Aerium Therapeutics
2
obfuscation
Omega FundsSeries A

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Aerium Therapeutics Logo
Series A - Aerium Therapeutics
2
obfuscation
Omega FundsSeries A
obfuscation
Series A - Aerium Therapeutics Logo
Series A - Aerium Therapeutics
2
obfuscation
Omega FundsSeries A
obfuscation
Series A - Aerium Therapeutics Logo
Series A - Aerium Therapeutics
2
obfuscation
Omega FundsSeries A
obfuscation
Series A - Aerium Therapeutics Logo
Series A - Aerium Therapeutics
2
obfuscation
Omega FundsSeries A
obfuscation
Series A - Aerium Therapeutics Logo
Series A - Aerium Therapeutics
2
obfuscation
Omega FundsSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Board Members and Advisors 3 Contacts 10

Employee Profiles

Board Members and Advisors

News

News and Press

News•Feb 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 6, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$80.3KThis year, Aerium Therapeutics is projected to spend $80.3K on IT, according to Aberdeen.

Active Website Tech Count

3Aerium Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  About Cookies.
Sub-Organizations
Frequently Asked Questions

Where is Aerium Therapeutics's headquarters? Aerium Therapeutics is located in Boston, Massachusetts, United States.Who invested in Aerium Therapeutics? Aerium Therapeutics has 2 investors including F-Prime and  Omega Funds.When was the last funding round for Aerium Therapeutics? Aerium Therapeutics closed its last funding round on
obfuscation
from a Series A round.Who are Aerium Therapeutics's competitors? Alternatives and possible competitors to Aerium Therapeutics may include Invivyd, Absci, and  Vir Biotechnology.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|